Predict your next investment

Private Equity
galen.com

See what CB Insights has to offer

Investments

57

Portfolio Exits

21

Funds

6

About Galen Partners

Galen Partners is a private equity financing firm. The firm focuses on growth equity investments in health care technology-enabled services, medical devices, and specialty pharmaceutical companies.

Galen Partners Headquarter Location

680 Washington Boulevard 11th Floor

Stamford, Connecticut, 06901,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Galen Partners News

Ex-CCO of InTouch Health to Join Galen as Special Investment Partner

Sep 9, 2020

Steve Cashman to join Galen Partners as Special Investment Partner ('SIP') News provided by Share this article STAMFORD, Conn., Sept. 9, 2020 /PRNewswire/ -- Steve Cashman, a veteran of the virtual healthcare space and ex-CCO of InTouch Health, has joined Galen Partners, a leading healthcare-focused growth equity investment firm, as Special Investment Partner ("SIP"). Galen Partners As the CCO of InTouch, Steve Cashman was instrumental in facilitating several key acquisitions that helped transform the InTouch platform into the first true enterprise telehealth solution. He will now join a group of 15 SIPs, comprised of highly respected seasoned healthcare executives, that work directly with Galen to identify investment opportunities and drive value to Galen's existing portfolio. Steve is looking to replicate the success of InTouch and will help lead Galen's proactive efforts in the virtual care space to identify attractive platform investment opportunities that help demonstrably improve clinical outcomes, lower costs and increase patient satisfaction. "Steve is highly regarded across the virtual healthcare industry and is well-known for his ability to drive growth and build value. We are pleased that Galen will benefit from his vast expertise as the healthcare technology dimension of all our investments become increasingly more important in today's changing landscape," said David Jahns, Managing Director at Galen. "We believe Steve's extensive leadership experience in the healthcare industry will be instrumental in supporting our team to build and grow great companies and find compelling investment opportunities across the virtual care landscape." "Having already worked hand in hand with Galen to successfully scale InTouch Health, I'm excited to join their mission of identifying additional platform opportunities in the virtual care space," says Steve. "The pandemic has highlighted the need to leverage technology to improve clinical outcomes and reduce cost, and our work together will be on the forefront of that effort." About Galen Partners Founded in 1990, Galen Partners is a leading healthcare-focused growth equity investment firm. Over the firm's history, Galen has raised six dedicated funds totaling nearly $1 billion and has invested in over 80 leading healthcare companies. Galen continues a tradition of strategic collaboration and partnership with founders and management teams to build healthcare market leaders. Media Contact:

Galen Partners Investments

57 Investments

Galen Partners has made 57 investments. Their latest investment was in CDx Diagnostics as part of their Recap on July 7, 2017.

CBI Logo

Galen Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/11/2017

Recap

CDx Diagnostics

Yes

3

4/12/2016

Series C

Ajinomoto Cambrooke

No

4

5/28/2015

Series D

Life Image

$17.5M

No

4

7/29/2013

Unattributed VC - III

Subscribe to see more

$99M

Subscribe to see more

10

4/18/2013

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/11/2017

4/12/2016

5/28/2015

7/29/2013

4/18/2013

Round

Recap

Series C

Series D

Unattributed VC - III

Series C

Company

CDx Diagnostics

Ajinomoto Cambrooke

Life Image

Subscribe to see more

Subscribe to see more

Amount

$17.5M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

4

4

10

10

Galen Partners Portfolio Exits

21 Portfolio Exits

Galen Partners has 21 portfolio exits. Their latest portfolio exit was Sharecare on July 01, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/1/2021

Reverse Merger

$99M

4

4/27/2021

Acquired

$99M

10

1/20/2021

Acquired

$99M

5

1/13/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

11/10/2017

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/1/2021

4/27/2021

1/20/2021

1/13/2020

11/10/2017

Exit

Reverse Merger

Acquired

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

4

10

5

10

10

Galen Partners Acquisitions

2 Acquisitions

Galen Partners acquired 2 companies. Their latest acquisition was Evolve Treatment Centers on January 08, 2020.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/8/2020

$99M

Acq - Fin

2

12/10/2003

Series B

Subscribe to see more

$99M

$99M

Subscribe to see more

0

Date

1/8/2020

12/10/2003

Investment Stage

Series B

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

$99M

Note

Acq - Fin

Subscribe to see more

Sources

2

0

Galen Partners Fund History

6 Fund Histories

Galen Partners has 6 funds, including Galen Evolve SPV.

Closing Date

Fund

Fund Type

Status

Amount

Sources

10/15/2019

Galen Evolve SPV

$20M

1

10/15/2019

Galen Partners VI Annex Fund

$99M

10

7/20/2017

Galen CDx SPV

$99M

10

7/20/2017

Galen CDx SPV II

$99M

10

7/20/2017

Galen CDx SPV III

$99M

10

Closing Date

10/15/2019

10/15/2019

7/20/2017

7/20/2017

7/20/2017

Fund

Galen Evolve SPV

Galen Partners VI Annex Fund

Galen CDx SPV

Galen CDx SPV II

Galen CDx SPV III

Fund Type

Status

Amount

$20M

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

Galen Partners Team

8 Team Members

Galen Partners has 8 team members, including current President, Bill Williams.

Name

Work History

Title

Status

Judith Starkey

Founder

Current

Bill Williams

President

Current

David Jahns

Managing Director

Current

Steve Shapiro

Managing Director

Current

Zubeen Shroff

Managing Director

Current

Name

Judith Starkey

Bill Williams

David Jahns

Steve Shapiro

Zubeen Shroff

Work History

Title

Founder

President

Managing Director

Managing Director

Managing Director

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.